160311 - Emotra - PM - First stage of study completed
The first stage of our clinical study has now been completed
read more
News archive
Short update – Grant Agreement signed with the European Commission
160303- Emotra - Newsletter- Grant Agreement signed
A short update from Emotra – Kickoff for Horizon 2020 and a conference in Madrid
160218- Emotra - Newsletter - Kickoff H2020
Emotra AB (publ) Full year report 2015
160211- Full-year report 2015
Emotra granted financial support from the EU Horizon 2020
Emotra AB announces that the Company has been granted financial support from the EU Horizon 2020 programme. The application, submitted in December 2015, is for a €50K grant to finance a phase 1 feasibility study to demonstrate the potential to broaden the EDOR...
A short update from Emotra – Presentation in Sao Paolo
Lars-Håkan Thorell, the inventor of EDOR, has been invited to be one of the keynote speakers at a large conference on bipolar disorders being held in Sao Paulo, Brazil, on August 22–23, 2016. At this conference he will present EDOR and the research behind the method,...
Presentation of Emotra and EDOR at Stora Aktiedagen
151118 - Emotra - News letter - Presentation at Stora Aktiedagen in Göteborg
Presentations by Thorell and Sarchiapone at a conference in Łódź
151116 - Emotra - Newsletter - appearances at the conference in Lodz
Article from Laika
151103- Emotra - Newsletter - Article from Laika
Situation Report
151027- Emotra - News letter- Situation report